When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
RUBY - Rubius Therapeutics falls on initial data for RTX-240 in solid tumors
Rubius Therapeutics Inc.
Rubius Therapeutics (RUBY) has reversed early gains in premarket hours after the company reported initial data from its ongoing Phase 1/2 clinical trial of RTX-240 in patients with advanced solid tumors. The stock is trading ~14.1% lower currently.“We believe these data provide clinical validation of our RED PLATFORM® and de-risk our oncology pipeline of Red Cell Therapeutics,” commented Pablo J. Cagnoni, CEO of Rubius.More details to follow….